Malignant paraganglioma of the urinary bladder. Description of clinical cases
https://doi.org/10.17650/1726-9776-2016-12-3-102-108
Abstract
Paraganglioma is hormonally active tumor originating from chromaffin tissue of sympathoadrenal system that secrete large amounts of catecholamines. Paraganglioma of the urinary bladder is a rare neoplasm, constituting approximately 0.06 % of all tumors of this localization. It is believed that this disease arises from embryonic remnants of chromaffin cells in the sympathetic plexus of the detrusor. Up to 10 % of these tumors have malignant origin. Diagnosis and tactics of treatment of patients with malignant paragangliomas of the bladder presents certain difficulties. The article describes 2 clinical observations of patients with this bladder pathology.
About the Authors
A. V. KhaylenkoRussian Federation
24 Kashirskoye shosse, Moscow, 115478
Department of Oncology the Faculty of Additional Professional Education
1 Ostrovityanova St., Moscow, 117997
K. M. Figurin
Russian Federation
24 Kashirskoye shosse, Moscow, 115478
A. P. Kazantsev
Russian Federation
24 Kashirskoye shosse, Moscow, 115478
D. V. Rybakova
Russian Federation
24 Kashirskoye shosse, Moscow, 115478
A. G. Perevoshchikov
Russian Federation
24 Kashirskoye shosse, Moscow, 115478
K. A. Romanova
Russian Federation
24 Kashirskoye shosse, Moscow, 115478
References
1. Das S, Bulusu NV, Lowe P. Primary vesical paraganglioma. Urology 1983;21:20–5.
2. Murphy WM, Beckwith JB, Farrow GM. Tumors of the kidney, bladder and related urinary structures. In: Rosai J, Sobin LH, editors. Atlas of tumor pathology. 3rd ed. Washington, DC: Armed Forces Institute of Pathology; 1994. p. 272–3.
3. Thrasher JB, Rajan RR, Perez LM, Humphrey PA, Anderson EE. Pheochromocytoma of urinary bladder: contemporary methods of diagnosis and treatment options. Urology 1993;41:435–9.
4. Gyftopoulos K, Perimenis P, Ravazolua P, Athanassopoulos A Pheochromocytoma of the urinary bladder presenting only with macroscopic hematuria. Urol Int 2000;65:173–5.
5. Dahm P, Gschwend JE. Malignant non-urothelial neoplasms of the urinary bladder: a review. Eur Urol 2003;44:672 - 81.
6. Grignon DJ, Ro JY, Mackay B, et al. Paraganglioma of the urinary bladder: immunohistochemical, ultrastructural, and DNA flow cytometric studies. Hum Pathol 1991;22:1162–9.
7. Zimmerman IJ, Biron RE, MacMahon HE. Pheochromocytoma of the urinary bladder. New Engl J Med 1953;249:25–6.
8. Piedrola G, Lopez E, Rueda MD, Lopez R, Serrano J, Sancho M. Malignant pheochromocytoma of the bladder: current controversies. Eur Urol 1997;31:122–5.
9. Whalen RK, Althausen AF, Daniels GH. Extra-adrenal pheochromocytoma. J Urol 1992;147:1–10.
10. Honma K. Paraganglia of the urinary bladder. An autopsy study. Zentralbl Pathol 1993;139:465–9.
11. Cheng L, Leibovich B, Cheville J, et al. Paraganglioma of the urinary bladder: can biologic potential be predicted? Cancer 2000;88:844- 52 .
12. Young WF. Paragangliomas: clinical overview. Ann N Y Acad Sci 2006;1073:21e9.
13. Joynt KE, Moslehi JJ, Baughman KL. Paragangliomas: etiology, presentation, and management. Cardiol Rev 2009;17:159e64.
14. Heyman J, Cheung Y, Ghali V, Leiter E. Bladder pheochromocytoma; evaluation with magnetic resonance imaging. J Urol 1989;141:1424–6.
15. Frydenberg M, Ferguson R, Langdon P, Rogers J, McCarthy S. Malignant pheochromocytoma of the bladder. active or inactive. Br J Urol 1991;67:548–9.
16. Wong-You-Cheong JJ, Woodward PJ, Manning MA, Sesterhenn IA. From the Archives of the AFIP, neoplasms of the urinary bladder, radiologic-pathologic correlation. Radiographics 2006;26:553e80.
17. Baima C, Casetta G, Vella R, Tizzani A. Bladder pheochromocytoma: a 3-year follow-up after transurethral resection (TURB). Urol Int 2000;65:176–8.
18. Sweetser PM, Ohl DA, Thompson NW. Pheochromocytoma of the urinary bladder. Surgery 1991;109:677–81.
19. Ochi K, Yoshioka S, Morita M, Takeuchi M. Pheochromocytoma of the bladder. Urology 1981;17:228–30.
20. Muro Ovejas C, Zapater Serrano I, Martinez Mata A, de Arriba Villamor C, Ros Mendoza L. Magnetic resonance in the diagnosis of bladder pheochromocytoma. Arch Esp Urol 1997;50:912–4.
21. Troncone L, Rufini V, Montemaggi P, Danza FM, Lasorella A, Mastrangelo R. The diagnostic and therapeutic utility of radioiodinated metaiodobenzylguanidine: 5 years of experience. Eur J Nucl Med 1990;16:325–35.
22. Singh DV, Seth A, Gupta NP, Kumar M. Calcified non-functional paraganglioma of the urinary bladder mistaken as bladder calculus: a diagnostic pitfall. BJU Int 2000;85:1152–3.
23. Asbury Jr WI, Hatcher PA, Gould HR, Reeves WA, Wilson DD. Bladder pheochromocytoma with ring calcification. Abdom Imag 1996;21:275–7.
24. Takezawa Y, Inoue M, Kurita S, et al. Pheochromocytoma of the urinary bladder: a case report. Acta Urol Jpn 2001;47:105–7.
25. M, Caceres M, Thomas Jr CR, Herman TS, Eng TY. Radiation treatment of recurrent pheochromocytoma of the bladder: case report and review of literature. Am J Clin Oncol 2002;25:42–4.
26. Averbuch SD, Steakley CS, Young RC, et al. Malignant pheochromocytoma. Effective treatment with a combination of cyclophosphamide, vincristine, and dacarbazine. Ann Intern Med 1988;109: 267–73.
27. Yoshida S, Nakagomi K, Goto S, Kobayashi S. Malignant pheochromocytoma of the urinary bladder: effectiveness of radiotherapy in conjuction with chemotherapy. Int J Urol 2004;11:175–7.
28. Naguib M, Caceres M, Thomas Jr CR, Herman TS, Eng TY. Radiation treatment of recurrent pheochromocytoma of the bladder: case report and review of literature. Am J Clin Oncol 2002;25:42–4.
29. Atiyeh BA, Barakat AJ, Abumrad NN. Extra-adrenal pheochromocytoma. J Nephrol 1997;10:25–9.
Review
For citations:
Khaylenko A.V., Figurin K.M., Kazantsev A.P., Rybakova D.V., Perevoshchikov A.G., Romanova K.A. Malignant paraganglioma of the urinary bladder. Description of clinical cases. Cancer Urology. 2016;12(3):102-108. https://doi.org/10.17650/1726-9776-2016-12-3-102-108